George Putnam
The Turnaround Letter
Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Nicholas Vardy
Bull Market Alert

Dreman (DRSVX): Small cap value


Bookmark and Share

By Louis Basense, contributing editor The Oxford Club

Louis Basenese Oford ClubIt's not secret that small caps perform best coming out of recessions. Further, if we want to ride the small-cap rally for maximum gains, we should similarly rotate into small-cap value stocks.

Thankfully, it’s an easy transition to make. I say that because the most attractive small-cap value investment is sitting right under our noses. No one on Earth is better at discovering small-cap value investments than David Dreman.

In fact, over the last five years, he’s beaten the small-cap value index handily, by an average of 7% per year. (He’s outperformed the index over the last decade, too.) 

Advertisement
Banner

History clearly dictates a rotation into higher quality, undervalued small caps as this bull market progresses. However, this go-round could mark the most pronounced rotation ever. I say that because I expect private equity shops – flush with $1 trillion in cash – to return with a vengeance. 

After all, mergers and acquisitions (M&A) activity always picks up coming out of recessions, too. And financing no longer exists for the mega-billion dollar deals. So it stands to reason that the next M&A boom will be fueled by an abundance of smaller deals. 

Dreman's long-term outperformance is no accident. He pays great attention to the stock-filtering process. He insists on companies with market caps between $300 million and $2.5 billion, trading at a discount to the market and industry price-to-earnings ratio, with low leverage, low price-to-book and price-to-cash flow ratios, strong management teams and a catalyst that could spur future growth.

Or, more plainly put, he does much more than look for companies that investors have discarded. He unearths the most undervalued, highest quality companies. Such a systematic approach and impressive track record is precisely why we added his Dreman Contrarian Small Cap Value Fund (DRSVX) to our All-Star Portfolio last summer.

We’re already sitting on a 28% return, thanks to the sweeping rally in small-cap stocks. But with the rotation into value stocks imminent – and a small-cap rally well underway – the returns should kick into overdrive in the year ahead. 

Remember, the fund allows us to buy 95 to 100 of the most compelling small-cap value stocks in the market. And if you believe in buying low and selling high, this is your opportunity. The average stock in the fund trades for a price-to-earnings ratio of 11 – a whopping 81% discount to the average stock in the S&P 500. 

Clearly, plenty of upside remains as these stocks play catch-up with the rest of the market. If you haven’t purchased the Dreman fund yet, do so before it’s too late. If you already own it, consider doubling down. This time next year I’m confident you’ll be glad you did. 

History clearly dictates a rotation into higher quality, undervalued small caps as this bull market progresses. However, this go-round could mark the most pronounced rotation ever. I say that because I expect private equity shops – flush with $1 trillion in cash – to return with a vengeance. 

After all, mergers and acquisitions (M&A) activity always picks up coming out of recessions, too. And financing no longer exists for the mega-billion dollar deals. So it stands to reason that the next M&A boom will be fueled by an abundance of smaller deals. That bodes well for the individual holdings in the Dreman fund, and in turn our profitability, as they could be acquired. 

Learn more about this financial newsletter at The Oxford Club.



News Flash

Goldcorp: 'My favorite major'
by Curtis Hesler, editor Professional Timing Service

The secular bull in gold and the commodity sector is not over. However, it is not at the ground floor any longer either; as such, stock selection must be more carefully considered.


Read more...

 

Money manager's small cap buys
by Jim Oberweis Jr., editor The Oberweis Report

Small-cap growth stock valuations are cheap, and like most things in life, economies are cyclical, even if this is a long and painful one. For the rare, brave contrarian with a reasonably long time horizon, that spells opportunity.


Read more...


   

Opportunities in homebuilding?
by Bernie Schaeffer, editor Schaeffer's Investment Research

Based on our "expectational analysis" strategy -- which  combines fundamental, sentiment and technical metrics -- I initiated long positions in two homebuilding stocks: Lennar Corporation (LEN) and Toll Brothers (TOL).


Read more...

 

Cliffs Natural: A DRIP favorite
by Vita Nelson, editor MoneyPaper

Our latest featured dividend reinvestment stock is Cliffs Natural Resources (CLF). Founded in 1847, the former Cleveland-Cliffs is the largest producer of iron ore pellets in North America.


Read more...

 

S&P's trio of info tech ETFS
by Dylan Cathers, S&P Capital IQ Equity Analyst, S&P The Outlook

Information technology is one of four sectors that S&P Capital IQ’s Sector Strategy Group currently recommends investors overweight in their portfolios.


Read more...

 

Crescent Point: Bakken bet
by Brian Hicks, editor Wealth Advisory

Master Limited Partnerships (MLPs) are unique investments that combine the tax benefits of a limited partnership (LP) with the liquidity of common stock.


Read more...

 

Natural gas: A bottom?
by Jason Cimpl, editor Daily Profit

Natural gas has collapsed for the past four years and has been on a gradual decline for almost a decade. Prices topped near $16 in 2005 and then declined to $2. So did natural gas just bottom?


Read more...

 

FBR Focus bests 99% of peers
by Walter Frank, editor MoneyLetter

Funds that invest in a relatively few stocks or sectors are less diversified than broadly invested funds and their volatility can be much higher. But the team at FBR Focus (FBRVX) seems to be getting it right.


Read more...

 

Celgene: Catalysts ahead
by John McCamant, editor Medical Technology Stock Letter

Celgene (CELG) recently kicked off the 2012 JP Morgan Healthcare conference by pre-announcing 4Q11 results and providing 2012 guidance.


Read more...

 

Water, water
by Richard Band, editor Profitable Investing

In the current environment, investors should focus any new stock purchases on companies with recession-resistant franchises and generous dividends -- such as water utilities.


Read more...